doctor head
 
  pharmacy and drugs  
search Search
 
       About us       News      A-Z Drugs      Stores      Top Drugs      Contact  
  doctor doctor hand
 
  doctor legs  
 
 
 
 

  Diseases

  Newsletter
Subscribe to our newsletter:
Name:
E-mail:
    Search results
Search results for: amphetamine

1 - 5 of 7 <<previous | next>>

Drugs results:

Phentermine

Phentermine

Phentermine is one of a class of drugs known as Sympathomimetic Appetite Suppressants. Also called Adipex, it is used in the short-term treatment of obesity. The appetite-reducing effect of Phentermine tends to decrease after a few weeks, and these medici more...

Adipex tablet

Adipex

Adipex is one of a class of drugs known as Sympathomimetic Appetite Suppressants. Also called Phentermine, it is used in the short-term treatment of obesity. The appetite-reducing effect of Adipex tends to decrease after a few weeks, and these medicines a more...

Methamphetamine tablets

Methamphetamine

Methamphetamine is one of a group of medicines known as Central Nervous System (CNS) stimulants. They are used to treat Attention-Deficit Hyperactivity Disorder (ADHD). Methamphetamines are also used in the treatment of Narcolepsy, a sleeping disorder. more...

Adderall tablets

Adderall

Adderall (also known as Dextroamphetamine and amphetamine) is one of a group of medicines known as Central Nervous System (CNS) stimulants. They are used to treat Attention-Deficit Hyperactivity Disorder (ADHD). Amphetamines are also more...

Bontril tablets

Bontril

Often called Phendimetrazine, Bontril is a Sympathomimetic Appetite Suppressants used in the short-term treatment of obesity. Since their appetite-reducing effect tends to decrease after a few weeks, these medicines are useful only during the first few we more...

Diseases results:

Obesity
Narcolepsy
Sleep disorder
Addiction
Psychosis
Pulmonary Hypertension

Articles results:

Novel Treatment For ADHD - Shire And New River Pharmaceuticals Announce FDA Approval Of The First And Only Stimulant Prodrug VYVANSE
Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) and its collaborative partner New River Pharmaceuticals Inc. (NASDAQ: NRPH) announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for VYVANSE (lisdexamfetamine dimesylate, formerly known as NRP104), for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). On February 20, 2007 Shire and New River announced an agreement whereby Shire will acquire New River for approximately $2.




1 - 5 of 7 <<previous | next>>

© 2006-2010 pharmacy-and-drugs.com. All rights reserved.